Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Nov;66(5):961–969. doi: 10.1038/bjc.1992.393

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

A Ravaud 1, N B Bui 1, J M Coindre 1, P Lagarde 1, P Tramond 1, F Bonichon 1, E Stöckle 1, G Kantor 1, M Trojani 1, J Chauvergne 1, et al.
PMCID: PMC1977996  PMID: 1419644

Abstract

From 1975 to 1988, 144 patients naive of treatment, with non-metastatic soft tissue sarcoma were treated at Fondation Bergonié by surgery, followed by radiotherapy and without chemotherapy. An analysis of prognostic variables was done on this population to determine patients for whom an adjuvant chemotherapy would be relevant. Prognostic variables in overall survival (OS), metastasis-free survival (MFS), disease-free and local free recurrence survivals were analysed by univariate and multivariate analysis. In multivariate analysis using Cox's model, only tumour depth and tumour grade were significant with the MFS end point, while tumour depth, tumour grade and tumour site were significant when considering OS. A predictive stratification for patients is proposed: a favourable prognostic group with grade 1 tumour or superficial, grade 2 tumour (5-year OS: 97.8%; 5-year MFS: 100%); an intermediate prognostic group with deep, grade 2 tumour or superficial, grade 3 tumour (5-year OS: 58.8%; 5-year MFS: 48.1%); and finally a poor prognostic group with deep, grade 3 tumour (5-year OS: 31.7%; 5-year MFS: 34.1%). Patients in the intermediate and poor prognostic groups who present a high metastatic risk are to be considered for adjuvant chemotherapy trials.

Full text

PDF
961

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coindre J. M., Trojani M., Contesso G., David M., Rouesse J., Bui N. B., Bodaert A., De Mascarel I., De Mascarel A., Goussot J. F. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986 Jul 15;58(2):306–309. doi: 10.1002/1097-0142(19860715)58:2<306::aid-cncr2820580216>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  2. Collin C., Godbold J., Hajdu S., Brennan M. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987 Apr;5(4):601–612. doi: 10.1200/JCO.1987.5.4.601. [DOI] [PubMed] [Google Scholar]
  3. Elias A. D., Antman K. H. Adjuvant chemotherapy for soft tissue sarcoma: an approach in search of an effective regimen. Semin Oncol. 1989 Aug;16(4):305–311. [PubMed] [Google Scholar]
  4. Enneking W. F., Spanier S. S., Malawer M. M. The effect of the Anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer. 1981 Mar 1;47(5):1005–1022. doi: 10.1002/1097-0142(19810301)47:5<1005::aid-cncr2820470532>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  5. Enterline H. T. Histopathology of sarcomas. Semin Oncol. 1981 Jun;8(2):133–155. [PubMed] [Google Scholar]
  6. Evenson D. P., Arlin Z., Welt S., Claps M. L., Melamed M. R. Male reproductive capacity may recover following drug treatment with the L-10 protocol for acute lymphocytic leukemia. Cancer. 1984 Jan 1;53(1):30–36. doi: 10.1002/1097-0142(19840101)53:1<30::aid-cncr2820530108>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  7. Heise H. W., Myers M. H., Russell W. O., Suit H. D., Enzinger F. M., Edmonson J. H., Cohen J., Martin R. G., Miller W. T., Hajdu S. I. Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer. 1986 Jan 1;57(1):172–177. doi: 10.1002/1097-0142(19860101)57:1<172::aid-cncr2820570133>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  8. Lack E. E., Steinberg S. M., White D. E., Kinsella T., Glatstein E., Chang A. E., Rosenberg S. A. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol. 1989 Aug;41(4):263–273. doi: 10.1002/jso.2930410414. [DOI] [PubMed] [Google Scholar]
  9. Lagarde P., Kantor G., Bussières E., Stöckle E., Coindre J. M., Tramond P., Avril A., Bui N. B., Marée D. Radiothérapie postopératoire des sarcomes des parties molles des membres. Analyse des volumes et des doses d'irradiation sur une série de 31 cas. Bull Cancer Radiother. 1990;77(2):101–109. [PubMed] [Google Scholar]
  10. Mandard A. M., Petiot J. F., Marnay J., Mandard J. C., Chasle J., de Ranieri E., Dupin P., Herlin P., de Ranieri J., Tanguy A. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989 Apr 1;63(7):1437–1451. doi: 10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Markhede G., Angervall L., Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982 Apr 15;49(8):1721–1733. doi: 10.1002/1097-0142(19820415)49:8<1721::aid-cncr2820490832>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  12. Potter D. A., Kinsella T., Glatstein E., Wesley R., White D. E., Seipp C. A., Chang A. E., Lack E. E., Costa J., Rosenberg S. A. High-grade soft tissue sarcomas of the extremities. Cancer. 1986 Jul 1;58(1):190–205. doi: 10.1002/1097-0142(19860701)58:1<190::aid-cncr2820580133>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  13. Presant C. A., Russell W. O., Alexander R. W., Fu Y. S. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986 Nov;4(11):1658–1661. doi: 10.1200/JCO.1986.4.11.1658. [DOI] [PubMed] [Google Scholar]
  14. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Baker A., Brennan M., DeMoss E. V., Seipp C., Sindelar W. F., Sugarbaker P. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982 Sep;196(3):305–315. doi: 10.1097/00000658-198209000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rouëssé J. G., Friedman S., Sevin D. M., le Chevalier T., Spielmann M. L., Contesso G., Sarrazin D. M., Genin J. R. Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas. Cancer. 1987 Aug 1;60(3):296–300. doi: 10.1002/1097-0142(19870801)60:3<296::aid-cncr2820600305>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  16. Russell W. O., Cohen J., Enzinger F., Hajdu S. I., Heise H., Martin R. G., Meissner W., Miller W. T., Schmitz R. L., Suit H. D. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977 Oct;40(4):1562–1570. doi: 10.1002/1097-0142(197710)40:4<1562::aid-cncr2820400428>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  17. Shiraki M., Enterline H. T., Brooks J. J., Cooper N. S., Hirschl S., Roth J. A., Rao U. N., Enzinger F. M., Amato D. A., Borden E. C. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer. 1989 Jul 15;64(2):484–490. doi: 10.1002/1097-0142(19890715)64:2<484::aid-cncr2820640223>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  18. Stotter A. T., A'Hern R. P., Fisher C., Mott A. F., Fallowfield M. E., Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer. 1990 Mar 1;65(5):1119–1129. doi: 10.1002/1097-0142(19900301)65:5<1119::aid-cncr2820650515>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  19. Suit H. D., Mankin H. J., Wood W. C., Proppe K. H. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer. 1985 Jun 1;55(11):2659–2667. doi: 10.1002/1097-0142(19850601)55:11<2659::aid-cncr2820551122>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  20. Trojani M., Contesso G., Coindre J. M., Rouesse J., Bui N. B., de Mascarel A., Goussot J. F., David M., Bonichon F., Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984 Jan 15;33(1):37–42. doi: 10.1002/ijc.2910330108. [DOI] [PubMed] [Google Scholar]
  21. Tsujimoto M., Aozasa K., Ueda T., Morimura Y., Komatsubara Y., Doi T. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer. 1988 Sep 1;62(5):994–998. doi: 10.1002/1097-0142(19880901)62:5<994::aid-cncr2820620526>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  22. Ueda T., Aozasa K., Tsujimoto M., Hamada H., Hayashi H., Ono K., Matsumoto K. Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer. 1988 Oct 1;62(7):1444–1450. doi: 10.1002/1097-0142(19881001)62:7<1444::aid-cncr2820620733>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES